Effect of Platelet-Rich Plasma in Nerve Regeneration After LASIK

Journal of refractive surgery (Thorofare, N.J.: 1995) (Impact Factor: 3.47). 03/2013; 29(3):213-9. DOI: 10.3928/1081597X-20130129-04
Source: PubMed


To investigate the effect of topical eye application of platelet-rich plasma (E-PRP) on the recovery of corneal sensitivity after LASIK and the anatomical recovery of the sub-basal corneal plexus as studied by confocal microscopy.
This was a randomized, consecutive, controlled, prospective and masked study on 108 myopic eyes receiving LASIK. The main variables of the study were the increase in corneal sensitivity (Cochet-Bonet aesthesiometer; Luneau, Paris, France) and the aspect of the sub-basal nerve plexus (confocal microscope). Additionally, a biomicroscopic study of the epithelial status of the cornea and a subjective questionnaire were completed. Each eye of each patient was assigned to one of two groups: 54 eyes treated with balanced saline solution and 54 fellow eyes receiving PRP drops for 3 months.
No significant differences were detected when the corneal sensitivity thresholds were compared at any postoperative visit in both groups (P > .05 for all comparisons). Almost identical sub-basal fiber densities were estimated for both groups before LASIK (t test, P = .66). However, the type and severity of staining detected during the slit-lamp examinations at the first and third month postoperatively were significantly less evident in the E-PRP treatment group (Wilcoxon test, P < .05).
PRP drops have beneficial effects for promoting epithelial status after LASIK but have no positive effect on recovery of corneal sensitivity, probably due to the limited bioavailability of growth factors in corneal stroma when the substance is topically administered.

1 Follower
27 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim was to evaluate the effect of autologous platelet-rich plasma on lacrimal function in patients with severe dry eye. A prospective interventional case series design was adopted. Four patients with severe lacrimal dysfunction and severe dry eye were treated. Platelet rich-activated plasma (1 mL) was injected adjacent to the lacrimal gland on day 0 and at 4, 8, and 12 weeks. The objective parameters included a Schirmer test, ocular surface staining, and tear break-up time (TBUT). The patients were followed up for 12 weeks after the first injection. All cases showed a significant improvement in lacrimal volume (from 3.3 ± 0.8 mm to 11.1 ± 2.3 mm). In all the patients, an increase in tear break-up time values and a decrease in ocular staining (basal 8.0 ± 0.61-2.8 ± 0.5) with subjective improvement occurred. None of the patients presented any adverse effect, and none reported pain or discomfort. Additionally, no complications were observed. Injected platelet-enriched plasma was found to be safe and effective in increasing lacrimal production and in improving ocular staining secondary to severe dry eye. This approach could be an alternative for the management of these patients, although additional studies are required to perfect the technique.
    Cornea 11/2013; 33(1). DOI:10.1097/ICO.0000000000000016 · 2.04 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Dry eye disease is a troublesome ocular condition due to its multifactorial nature and the lack of association between signs and symptoms. This fact has led researchers to look beyond tear quality and stability, and hyperosmolarity and inflammation have lately been the focus of interest. Both are considered to have an impact on corneal nerve structure and function, although their role is still unclear. In this review, we will explore the peripheral and central nervous system mechanisms that contribute to the perception of dry eye symptoms and the possible changes in corneal pain pathways after long-standing tear deficiency and LASIK surgery that could result in corneal sensitivity or enhanced pain perception.
  • [Show abstract] [Hide abstract]
    ABSTRACT: La queratectomía fotorrefractiva (PRK) remodela el estroma de la córnea para compensar los errores refractivos. La eliminación del epitelio y la ablación del estroma provoca la alteración de los nervios corneales y la liberación de diversos péptidos de la lágrima, epitelio, estroma y nervios. Innumerables citoquinas, factores de crecimiento y metaloproteasas de la matriz participan en el proceso de regeneración y cicatrización corneal. Su equilibrio determinará si la re-epitelización y la remodelación del estroma son adecuados. El objetivo final es el logro de la transparencia corneal para restablecer la función de la córnea, así como la calidad visual adecuada. Por tanto, la respuesta de regeneración y cicatrización corneal es esencial para el éxito de la cirugía refractiva. Nuestro objetivo es aportar una visión general sobre el modo en que se desarrolla dicho proceso tras la PRK. Revisaremos también la influencia de la aplicación intraoperatoria de mitomicina C, lentes de contacto terapéuticas, y otros fármacos para prevenir el haze y el dolor tras la PRK.
Show more